Cargando…

Lipoprotein(a): a not-so-well-known risk factor for the development of cardiovascular disease in patients with type 2 diabetes mellitus

Detalles Bibliográficos
Autor principal:	Moon, Min Kyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094938/ https://www.ncbi.nlm.nih.gov/pubmed/27809452 http://dx.doi.org/10.3904/kjim.2016.301

Ejemplares similares

The well-known and less well-known benefits of vaccines
por: Michel, Jean-Pierre
Publicado: (2020)

Are diabetes mellitus and lipoprotein(a) independently or causally associated with an increased cardiovascular risk?
por: Vavlukis, Marija
Publicado: (2017)

Sleep Disorder and Cardiovascular Risk Factors in Type 2 Diabetes Mellitus
por: Seo, Mi-Hae, et al.
Publicado: (2011)

Postprandial Lipoproteins and Cardiovascular Disease Risk in Diabetes Mellitus
por: Enkhmaa, Byambaa, et al.
Publicado: (2010)

Cardiovascular Outcomes according to Comorbidities and Low-Density Lipoprotein Cholesterol in Korean People with Type 2 Diabetes Mellitus
por: Moon, Min Kyong, et al.
Publicado: (2023)

Lipoprotein (a): A Novel Cardiovascular Risk Factor
por: Kozarova, Miriam, et al.
Publicado: (2023)

Ultra-Processed Foods as a Less-Known Risk Factor in Cardiovascular Diseases
por: Lee, Hae-Young
Publicado: (2021)

What’s Taking So Long? Known Unknowns, Capacity Strain, and Hospital-acquired Sepsis
por: Bowman, Amelia, et al.
Publicado: (2022)

Optimal Low-Density Lipoprotein Cholesterol Level for Primary Prevention in Koreans with Type 2 Diabetes Mellitus
por: Kim, Ji Yoon, et al.
Publicado: (2023)

Lipoprotein (a)—We Know So Much Yet Still Have Much to Learn …
por: Banach, Maciej
Publicado: (2016)

MON-342 Severe Hypocalcemia and Psuedotumor Cerebri: Old, Still Not so Well Known Relationship
por: Patil, Madhuri, et al.
Publicado: (2020)

Emerging Pathogens: Novel and Well-Known Infectious Threats in Transfusion Medicine
por: Dreier, Jens, et al.
Publicado: (2022)

Longitudinal association between egg consumption and the risk of cardiovascular disease: interaction with type 2 diabetes mellitus
por: Jang, Jiyoung, et al.
Publicado: (2018)

Why is understanding the relationship of testosterone to cardiovascular risk so important?
por: Yeap, Bu B, et al.
Publicado: (2018)

Risk factors of previously undiagnosed and known untreated hypertension among patients with Type-2 diabetes mellitus
por: Adnan, Muhammad, et al.
Publicado: (2023)

Experimental Cardiorenal Syndrome Type 3: What Is Known so Far?
por: Patschan, Daniel, et al.
Publicado: (2022)

The Search for Genetic Risk Factors of Type 2 Diabetes Mellitus
por: Park, Kyong Soo
Publicado: (2011)

Environmental Trigger(s) of Type 1 Diabetes: Why Is It So Difficult to Identify?
por: Rønningen, Kjersti S., et al.
Publicado: (2015)

Resistance Exercise and Cardiovascular Disease in Diabetes Mellitus
por: Yoon, Jin-Hwan
Publicado: (2022)

Type 2 Diabetes and Cardiovascular Risk in Women
por: Russo, Giuseppina T., et al.
Publicado: (2015)

Computed tomography colonography: a well-known but poorly utilized screening method
por: Maciel, Antonio Carlos, et al.
Publicado: (2014)

Cardiovascular risk in type 1 diabetes mellitus
por: Slim, Ines Ben Hadj Slama
Publicado: (2013)

Cardiovascular Risk in Type 1 Diabetes Mellitus
por: Schofield, Jonathan, et al.
Publicado: (2019)

Is Lipoprotein(a) the Most Important Predictor of Residual Atherosclerotic Cardiovascular Disease Risk?
por: Wong, Nathan D.
Publicado: (2022)

The known knowns, known unknowns, and unknown unknowns of surveys and sleep
por: Shaker, Marcus, et al.
Publicado: (2022)

Comparison of on-Statin Lipid and Lipoprotein Levels for the Prediction of First Cardiovascular Event in Type 2 Diabetes Mellitus
por: Kim, Ji Yoon, et al.
Publicado: (2023)

High-Density Lipoproteins in Non-Cardiovascular Diseases
por: Zanotti, Ilaria
Publicado: (2022)

Effects on Biomarkers in Stress Ecology Studies. Well, So What? What Now?
por: Lemos, Marco F. L., et al.
Publicado: (2022)

Novel Molecules in Diabetes Mellitus, Dyslipidemia and Cardiovascular Disease
por: Vesa, Cosmin Mihai, et al.
Publicado: (2023)

Type 2 Diabetes and Cardiovascular Risk in Women 2016
por: Kautzky-Willer, Alexandra, et al.
Publicado: (2017)

Elevated lipoprotein(a) levels predict cardiovascular disease in type 2 diabetes mellitus: a 10-year prospective cohort study
por: Lim, Tae-Seok, et al.
Publicado: (2016)

Association of sex-specific differences in lipoprotein(a) concentrations with cardiovascular mortality in individuals with type 2 diabetes mellitus
por: Markus, Marcello Ricardo Paulista, et al.
Publicado: (2021)

Could hyperglycemia-induced cardiac autoimmunity be hidden behind cardiovascular disease in type 1 diabetes mellitus?
por: Vallianou, Natalia, et al.
Publicado: (2019)

Navigating the Seas of Glycemic Control: The Role of Continuous Glucose Monitoring in Type 1 Diabetes Mellitus
por: Moon, Jun Sung
Publicado: (2023)

Simple Screening Using Ultrasonography for Prediction of Gestational Diabetes Mellitus
por: Chung, Seung Min, et al.
Publicado: (2017)

Are We in the Same Risk of Diabetes Mellitus? Gender- and Age-Specific Epidemiology of Diabetes in 2001 to 2014 in the Korean Population
por: Koo, Bo Kyung, et al.
Publicado: (2016)

12-Month prevalence of known diabetes mellitus in Germany
por: Heidemann, Christin, et al.
Publicado: (2017)

Small dense low-density lipoprotein as a potential risk factor of nephropathy in type 2 diabetes mellitus
por: Abd-Allha, Essam, et al.
Publicado: (2014)

High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad and the Future
por: Julve, Josep, et al.
Publicado: (2021)

High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad, and the Future
por: Julve, Josep, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j08h5eb835s9pb17og0be23tit